JP2011518136A5 - - Google Patents

Download PDF

Info

Publication number
JP2011518136A5
JP2011518136A5 JP2011504180A JP2011504180A JP2011518136A5 JP 2011518136 A5 JP2011518136 A5 JP 2011518136A5 JP 2011504180 A JP2011504180 A JP 2011504180A JP 2011504180 A JP2011504180 A JP 2011504180A JP 2011518136 A5 JP2011518136 A5 JP 2011518136A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
hydroxyestradi
epoxy
woman
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011504180A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011518136A (ja
JP5524177B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/040102 external-priority patent/WO2009126825A1/en
Publication of JP2011518136A publication Critical patent/JP2011518136A/ja
Publication of JP2011518136A5 publication Critical patent/JP2011518136A5/ja
Application granted granted Critical
Publication of JP5524177B2 publication Critical patent/JP5524177B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011504180A 2008-04-09 2009-04-09 ほてりのためのステロイド治療 Active JP5524177B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12362208P 2008-04-09 2008-04-09
US61/123,622 2008-04-09
PCT/US2009/040102 WO2009126825A1 (en) 2008-04-09 2009-04-09 Steroid treatment for hot flashes

Publications (3)

Publication Number Publication Date
JP2011518136A JP2011518136A (ja) 2011-06-23
JP2011518136A5 true JP2011518136A5 (enExample) 2012-05-31
JP5524177B2 JP5524177B2 (ja) 2014-06-18

Family

ID=41162250

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011504180A Active JP5524177B2 (ja) 2008-04-09 2009-04-09 ほてりのためのステロイド治療

Country Status (10)

Country Link
US (2) US20090258040A1 (enExample)
EP (1) EP2278880B1 (enExample)
JP (1) JP5524177B2 (enExample)
KR (1) KR101602802B1 (enExample)
CN (1) CN102056484B (enExample)
AU (1) AU2009234159B2 (enExample)
BR (1) BRPI0910637A2 (enExample)
DK (1) DK2278880T3 (enExample)
MX (1) MX2010011063A (enExample)
WO (1) WO2009126825A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018297270B2 (en) * 2017-07-06 2024-02-15 Dignity Health Novel treatment for hot flushes
DK3955933T3 (da) 2019-04-15 2024-02-12 Vistagen Therapeutics Inc Behandling af migræne
MX2025014339A (es) * 2023-06-04 2026-02-03 Vistagen Therapeutics Inc Metodo para mejorar el rendimiento cognitivo o psicomotor
US20250312356A1 (en) * 2024-04-08 2025-10-09 Vistagen Therapeutics, Inc. Treatment of dysmenorrhea

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1158966B (de) * 1961-04-29 1963-12-12 Schering Ag Verfahren zur Herstellung von 6-Chlor-1, 2ª‡-methylen-í¸-17ª‡-hydroxyprogesteronestern
US6140316A (en) * 1991-01-07 2000-10-31 Pherin Corporation Estrene steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions
US5303703A (en) * 1991-10-03 1994-04-19 Pherin Corporation Combined neuroepithelial sample delivery electrode device and methods of using same
US6057439A (en) * 1994-08-04 2000-05-02 Pherin Corporation Steroids as neurochemical stimulators of the VNO to alleviate symptoms of PMS and anxiety
US5563131A (en) * 1994-08-04 1996-10-08 Pherin Corporation Pregnane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
US6331534B1 (en) * 1994-08-04 2001-12-18 Pherin Pharmaceuticals, Inc. Steroids as neurochemical stimulators of the VNO to alleviate pain
US6066627A (en) * 1994-08-04 2000-05-23 Pherin Corporation Steroids as neurochemical initiators of change in human blood levels of LH
US5994333A (en) * 1994-08-04 1999-11-30 Pherin Corporation Pregnane and cholane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
US5792757A (en) * 1994-08-04 1998-08-11 Pherin Pharmaceuticals 19-nor-pregnane steroids as neurochemical initiators of change in human hypothalamic function
US6117860A (en) * 1994-08-04 2000-09-12 Pherin Pharmaceuticals, Inc. Steroids as neurochemical stimulators of the VNO to treat paroxistic tachycardia
JP4450435B2 (ja) * 1996-07-23 2010-04-14 フィーリン・ファーマシューティカルズ・インコーポレイテッド Pmsおよび不安の症状を緩和する、vnoにおける神経化学刺激物質としてのステロイド
US6165504A (en) * 1998-09-23 2000-12-26 Barr Laboratories, Inc. Methods for treating hot flashes and improving the quality of life of castrated prostatic cancer patients
US6613758B1 (en) 1999-04-02 2003-09-02 Barr Laboratories, Inc. Method for treating osteoporosis in castrated prostatic cancer patients
ES2204613T3 (es) * 1999-04-06 2004-05-01 Akzo Nobel N.V. Androgenos 7-alfa alquilo oralmente activos.
US20030045514A1 (en) * 2001-05-03 2003-03-06 Louis Monti 17-Methyleneandrostan-3alpha-ol analogs as CRH inhibitors
US7482029B2 (en) * 2005-04-01 2009-01-27 Bionovo, Inc. Composition for treatment of menopause
SI3045182T1 (en) * 2005-11-14 2018-08-31 Teva Pharmaceuticals International Gmbh An antibody to a peptide-associated peptide antagonist to calcitonin for treating a headache in aggregates
US20080293683A1 (en) 2007-05-24 2008-11-27 University Of Kansas Medical Center Hormone Replacement Therapy

Similar Documents

Publication Publication Date Title
IL203747A (en) Use of a steroid sex precursor in the manufacture of a 13mg dose or less for daily dosing through the vagina to treat vaginal diseases and a vaginal pharmacological preparation containing it
JP2012524112A5 (enExample)
JP2011225596A5 (enExample)
HRP20192189T1 (hr) Doziranja i terapijske primjene l-4-klorokinurenina
JP2011513437A5 (enExample)
MX2013003523A (es) Composicion farmaceutica de dosis baja.
KR20120085353A (ko) 가금류, 가축의 조류독감 및 호흡기 질환 치료제 및 예방제
MY172530A (en) Method for treating gynecological diseases
Santini Human respiratory syncytial virus and Th1 chemokines
JP2016504361A5 (enExample)
CN105327069A (zh) 一种疏肝中草药组合物的配方、制备方法及应用
JP2019535830A5 (enExample)
RU2015139515A (ru) Комбинированное лечение
CN103784590B (zh) 一种止脱生发中药配方
CL2015003014A1 (es) Composición farmacéutica que comprende 0,5-5 mg de (11?,17?)-17-hidroxi-11-[4-(metilsulfonil)fenil]-17-(pentafluoroetil)estra-4,9-dien-3-ona; forma de dosificación oral; uso para tratar y/o prevenir una enfermedad ginecológica, tal como, fibroides en el útero, endometriosis o hemorragias menstruales excesivas.
CN104666531A (zh) 一种小儿退热贴及其制备方法
CN107714777A (zh) 一种促进口腔溃疡痊愈的药物
CN102485242B (zh) 一种疏风清热解毒利咽的中药组合物及制备方法
CN102068676A (zh) 一种治疗冻疮的药物
CN104224808A (zh) 米诺环素用于妊娠期间应激所致的后代神经精神损伤的保护作用
CN106176967B (zh) 一种舒张气管平滑肌的药物组合物
CN101579389A (zh) 一种治疗骨质疏松症的药物组合物
JP2010519274A5 (enExample)
CN103893413A (zh) 一种用于治疗湿疹或皮肤瘙痒的药物组合物及制备方法
CN103263570B (zh) 一种用于治疗系统性红斑狼疮的中药组合物